Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Type A for Neuroma Pain
NCT01374191Phase 2Withdrawn
- Sponsor
- Southern Illinois University
- Start
- Jan 2015
- Primary completion
- May 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in Neuroma, sponsored by Southern Illinois University. Planned start Jan 2015; status: withdrawn.
02
Drugs
botulinum toxin type A
03
Conditions
Neuroma
Beyond the preview
Go deeper on NCT01374191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01374191.